St. Jude Medical
1 Lillehei Plaza
Saint Paul, MN 55117
Feature | EP Lab | June 22, 2017 | Dave Fornell
Electrophysiology (EP) technology has been advancing rapidly the past few years with new ablation tools to improve...
News | May 30, 2017
May 30, 2017 — Abbott recently announced European CE mark and first use of the new Confirm Rx Insertable Cardiac Moni
News | Structural Heart Occluders | February 15, 2017
Doctors at the University of Alabama at Birmingham have implemented the first U.S. Food and Drug Administration (FDA)-...
News | Structural Heart Occluders | February 01, 2017
Baylor Heart and Vascular Services at Fort Worth in November became the first program in Texas to implant the Amplatzer...
Feature | EP Lab | January 09, 2017 | Dave Fornell
FDA Confirms Cybersecurity Vulnerabilities of St. Jude’s Implantable Cardiac Devices, Merlin Transmitter
January 9, 2017 — The U.S.
News | Cardiovascular Business | January 05, 2017
January 5, 2017 — Abbott announced it completed the acquisition of St.
Technology | EP Mapping and Imaging Systems | January 03, 2017
St. Jude Medical Inc. announced U.S. Food and Drug Administration (FDA) clearance of its EnSite Precision™ cardiac...
News | Ventricular Assist Devices (VAD) | December 08, 2016
St. Jude Medical Inc. announced results of the MOMENTUM 3 U.S. IDE Clinical Study during a late-breaking clinical trial...
News | Stents | November 07, 2016
Imaging Study Finds Good Stent Strut Coverage, Low Restenosis With Bioresorbable and Durable Polymer DES
November 7, 2016 – Results from TRANSFORM-OCT, a prospective, randomized trial using optical coherence tomography (OC
News | Structural Heart Occluders | November 02, 2016
St. Jude Medical Inc. announced the long-term data from RESPECT, a landmark trial, during a First Report session at the...